Implementing NGS-based BRCA tumour tissue testing in FFPE ovarian carcinoma specimens: hints from a real-life experience within the framework of expert recommendations.

Daniela RiveraMichele PaudiceViviana GismondiGiorgia AnselmiValerio Gaetano Vellone Liliana Varesconull null

Published in: Journal of clinical pathology (2020)

A close collaboration between pathology and genetics units provides advantages in the implementation of BRCA tumour tissue testing. The development of tools for designing and interpreting complex testing in-house validation could improve process quality.

Keyphrases

quality improvement
primary care
clinical practice
breast cancer risk